coteauBeta Get App
HIVE

HIVE

$2.03
+2.53% Oct 21 close
Sector n/a Compare
-69%-47%-26%-4%+17%Oct 2025Oct 2026Apr 2026
HIVESPY
1W
-9.4%
1M
-41.7%
3M
-36.4%
6M
-21.9%
YTD
-21.3%
1Y
-63.1%

Live chart

Loading live chart…

For information only · Important disclosures

Grades vs sector

No sector grades for HIVE yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth
Outside this model's universe or screens
Momentum Top 15
Outside this model's universe or screens
Momentum Blend
Not in the current book
New Highs Growth
Outside this model's universe or screens
Coteau Long Book
Not in the current book

News

More news
No recent headlines.

Key stats

52-week range$1.75 – $6.03
Valuation and fundamentals

Valuation & fundamentals

Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +2 (DCF counts double).
▲DCF (base case)above the price by 113%
•Piotroski F-score5/9

Discounted cash flow

Bear
$3
+49%
growth 0% · disc. 10.2% · term. 2.0%
Base
$4
+113%
growth 5% · disc. 9.2% · term. 2.5%
Bull
$6
+201%
growth 8% · disc. 8.2% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal
Not enough data to run a reverse DCF.
Edit assumptions · recalculates instantly
Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Quality & financial health

Gross margin
-25.9%
Operating margin
–
FCF margin
17.0%
Net margin
-98.5%
Return on equity
-77.2%
Return on invested capital
–
Net debt / EBITDA
–
Current ratio
2.0×
Interest cover
–
Cash conversion (OCF/NI)
–
Piotroski F-score 5/9 · last two fiscal years
✗ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✗ No share dilution✓ Gross margin improved✓ Asset turnover improved

Analysts

No analyst targets available.

Annual history

FYRevenueNet incomeFree cash flow
2026$297.8M$-148.4M$62.3M
2025$115.3M$-3.0M$16.6M
2024$114.5M$26.5M$9.6M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR –.

Earnings

Next report: –
No EPS history available.
Insider trades
Perrill Dave
Director · 2026-10-07
SELL
$34.4K
Perrill Dave
Director · 2026-08-19
SELL
$271.9K
None
None · None
SELL
–
None
None · None
SELL
–

Stats refreshed – ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Free. Not investment advice. Unsubscribe anytime.

coteau

Independent research · Not investment advice · Important disclosures · Contact desk@coteau.app

Coteau Systematic Strategies publishes stock research and model portfolios. Results are hypothetical unless marked Live. Data: Yahoo Finance (15-min delayed), SEC EDGAR and the House Clerk.

Beta 0.9 · Oct 21, 2026